Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized-controlled Trial of Isoniazid Plus Highly Active Antiretroviral Therapy Against Placebo to Prevent Tuberculosis in HIV-infected Persons

NCT00463086 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT00463086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00463086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized-controlled Trial of Isoniazid Plus Highly Active Antiretroviral Therapy Against Placebo to Prevent Tuberculosis in HIV-infected Persons
Lead sponsor
University of Cape Town
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2007
Completion date
November 30, 2011
Enrollment
1,368 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, latent tuberculosis infection, tuberculosis